Deasyl is identified, in-licence, and develops novel chemistry into scalable processes used by major fine chemical, petrochemical players.
Deasyl has raised $104K in total funding. The most recent round was Debt Financing. The last funding was announced in July 2022.
Deasyl's investors include European Innovation Council, FONGIT Innovation Fund.
Deasyl is headquartered in Plan-les-ouates, Switzerland.
Deasyl is identified, in-licence, and develops novel chemistry into scalable processes used by major fine chemical, petrochemical players.
Deasyl is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deasyl — Funding & Investors." VCBacked, July 4, 2022, https://www.vcbacked.co/company/deasyl. Accessed October 30, 2026.
VCBacked. (2022). Deasyl — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/deasyl
{{cite web |title=Deasyl — Funding & Investors |url=https://www.vcbacked.co/company/deasyl |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated